Dr Nick Palmer (Liverpool Heart and Chest Hospital, Liverpool, UK) discusses the large multinational COMPLETE trial.
The aim of this comparative-effectiveness study was to determine whether routine angiographically-guided percutaneous coronary intervention (PCI) would prevent CV death or MI, compared with optimum guideline-directed medical therapy alone.
Filmed in London at BCIS ACI 2020.
Interviewer: Leiah Norcott
Videographer: Natacha Wienand / Dominic Woodruff